Assessing inorganic nanoparticle toxicity through omics approaches.


Journal

Nanoscale
ISSN: 2040-3372
Titre abrégé: Nanoscale
Pays: England
ID NLM: 101525249

Informations de publication

Date de publication:
15 Aug 2024
Historique:
medline: 15 8 2024
pubmed: 15 8 2024
entrez: 15 8 2024
Statut: aheadofprint

Résumé

In the last two decades, the development of nanotechnology has resulted in inorganic nanoparticles playing crucial roles in key industries, ranging from healthcare to energy technologies. For instance, gold and silver nanoparticles are widely used in rapid COVID-19 and flu tests, titania and zinc oxide nanoparticles are commonly found in cosmetic products, and superparamagnetic iron oxide nanoparticles have been clinically exploited as contrast agents and anti-anemia medicines. As a result, human exposure to nanomaterials is continuously increasing, raising concerns about their potential adverse health effects. Historically, the study of nanoparticle toxicity has largely relied on macroscopic observations obtained in different

Identifiants

pubmed: 39145718
doi: 10.1039/d4nr02328e
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Yanchen Li (Y)

Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen 52074, Germany. rmoltopallar@ukaachen.de.

Christopher Vulpe (C)

Center for Environmental and Human Toxicology, Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA.

Twan Lammers (T)

Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen 52074, Germany. rmoltopallar@ukaachen.de.

Roger M Pallares (RM)

Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen 52074, Germany. rmoltopallar@ukaachen.de.

Classifications MeSH